Jeon Ji Hyun, Hwang Yu Im, Shin Im Hee, Park Chan Woo, Yang Kwang Moon, Kim Hye Ok
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea .
Department of Medical Statistics & Informatics, School of Medicine, Catholic University of Daegu, Daegu, Korea .
J Korean Med Sci. 2016 Jul;31(7):1094-9. doi: 10.3346/jkms.2016.31.7.1094. Epub 2016 May 9.
The purpose of this study was to investigate risk factors that are associated with heterotopic pregnancy (HP) following in vitro fertilization (IVF)-embryo transfer (ET) and to demonstrate the outcomes of HP after the surgical treatment of ectopic pregnancies. Forty-eight patients from a single center, who were diagnosed with HP between 1998 and 2012 were included. All of the patients had received infertility treatments, such as Clomid with timed coitus (n = 1, 2.1%), superovulation with intrauterine insemination (n = 7, 14.6%), fresh non-donor IVF-ET (n = 33, 68.8%), and frozen-thawed cycles (n = 7, 14.6%). Eighty-four additional patients were randomly selected as controls from the IVF registry database. HP was diagnosed at 7.5 ± 1.2 weeks (range 5.4-10.3) gestational age. In six cases (12.5%), the diagnosis was made three weeks after the patients underwent treatment for abortion. There were significant differences in the history of ectopic pregnancy (22.5% vs. 3.6%, P = 0.002). There were no significant differences in either group between the rates of first trimester intrauterine fetal loss (15.0% vs. 13.1%) or live birth (80.0% vs. 84.1%) after the surgical treatment for ectopic pregnancy. The risk factors for HP include a history of ectopic pregnancy (OR 7.191 [1.591-32.513], P = 0.010), abortion (OR 3.948 [1.574-9.902], P = 0.003), and ovarian hyperstimulation syndrome (OHSS) (OR 10.773 [2.415-48.060], P = 0.002). In patients undergoing IVF-ET, history of ectopic pregnancy, abortion, and OHSS may be risk factors for HP as compared to the control group of other IVF patients. The surgical treatment of HP does not appear to affect the rates of first trimester fetal loss or live birth.
本研究的目的是调查体外受精(IVF)-胚胎移植(ET)后发生异位妊娠(HP)的相关危险因素,并展示异位妊娠手术治疗后HP的结局。纳入了来自单一中心的48例在1998年至2012年期间被诊断为HP的患者。所有患者均接受过不孕治疗,如克罗米酚联合定时性交(n = 1,2.1%)、超排卵联合宫内人工授精(n = 7,14.6%)、新鲜非供体IVF-ET(n = 33,68.8%)以及冻融周期(n = 7,14.6%)。另外从IVF登记数据库中随机选取84例患者作为对照。HP在孕龄7.5±1.2周(范围5.4 - 10.3周)时被诊断。在6例(12.5%)中,诊断是在患者接受流产治疗三周后做出的。异位妊娠史存在显著差异(22.5%对3.6%,P = 0.002)。异位妊娠手术治疗后,两组在孕早期宫内胎儿丢失率(15.0%对13.1%)或活产率(80.0%对84.1%)方面均无显著差异。HP的危险因素包括异位妊娠史(比值比7.191 [1.591 - 32.513],P = 0.010)、流产(比值比3.948 [1.574 - 9.902],P = 0.003)以及卵巢过度刺激综合征(OHSS)(比值比10.773 [2.415 - 48.060],P = 0.002)。与其他IVF患者的对照组相比,接受IVF-ET的患者中,异位妊娠史、流产和OHSS可能是HP的危险因素。HP的手术治疗似乎并不影响孕早期胎儿丢失率或活产率。